Norges Bank Sarepta Therapeutics, Inc. Transaction History

Norges Bank

  • $870 Trillion
  • Q3 2025

Shares

52 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$17.1 - $63.66 $15.6 Million - $58.1 Million
913,407 New
913,407 $15.6 Million
Q4 2024

Feb 12, 2025
BUY
$104.54 - $137.94 $109 Million - $143 Million
1,038,861 New
1,038,861 $126 Million
Q3 2024

Nov 12, 2025
BUY
$124.33 - $156.75 $11.6 Million - $14.6 Million
92,989 Added 10.18%
1,006,396 $126 Million
Q2 2024

Aug 14, 2024
BUY
$113.33 - $163.85 $105 Million - $151 Million
924,428 New
924,428 $146 Million
Q1 2024

May 14, 2025
BUY
$93.7 - $141.53 $90.8 Million - $137 Million
968,798 New
968,798 $125 Million
Q4 2023

Feb 09, 2024
BUY
$67.31 - $124.76 $56.3 Million - $104 Million
836,849 New
836,849 $80.7 Million
Q3 2023

Nov 13, 2024
BUY
$102.5 - $123.59 $83.3 Million - $100 Million
812,965 New
812,965 $98.5 Million
Q3 2023

Nov 13, 2023
SELL
$102.5 - $123.59 $85.7 Million - $103 Million
-836,318 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$106.4 - $157.19 $9.98 Million - $14.7 Million
-93,804 Reduced 10.15%
830,624 $95.1 Million
Q2 2023

Aug 14, 2023
SELL
$106.4 - $157.19 $79.4 Million - $117 Million
-746,132 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$117.53 - $155.99 $90 Million - $119 Million
766,010 New
766,010 $106 Million
Q4 2022

Feb 14, 2023
BUY
$100.86 - $132.13 $87.1 Million - $114 Million
863,721 New
863,721 $112 Million
Q3 2022

Nov 13, 2023
BUY
$75.71 - $119.24 $63.3 Million - $99.7 Million
836,318 New
836,318 $92.4 Million
Q2 2022

Aug 14, 2023
BUY
$62.69 - $88.44 $46.8 Million - $66 Million
746,132 New
746,132 $55.9 Million
Q1 2022

May 12, 2023
SELL
$63.15 - $90.42 $11.1 Million - $15.8 Million
-175,132 Reduced 20.28%
688,589 $53.8 Million
Q1 2022

May 09, 2022
SELL
$63.15 - $90.42 $41.3 Million - $59.2 Million
-654,753 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$77.28 - $99.42 $50.6 Million - $65.1 Million
654,753 New
654,753 $59 Million
Q3 2021

Nov 14, 2022
BUY
$65.97 - $92.48 $41.9 Million - $58.8 Million
635,708 New
635,708 $58.8 Million
Q3 2021

Nov 05, 2021
SELL
$65.97 - $92.48 $43.6 Million - $61.1 Million
-660,271 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$69.38 - $86.75 $45.8 Million - $57.3 Million
660,271 New
660,271 $51.3 Million
Q2 2021

Aug 10, 2021
SELL
$69.38 - $86.75 $46.8 Million - $58.5 Million
-674,002 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$72.25 - $168.95 $48.7 Million - $114 Million
674,002 New
674,002 $50.2 Million
Q1 2021

May 07, 2021
SELL
$72.25 - $168.95 $33.8 Million - $79 Million
-467,754 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$125.56 - $178.74 $58.7 Million - $83.6 Million
467,754 New
467,754 $79.7 Million
Q4 2020

Feb 10, 2021
SELL
$125.56 - $178.74 $62.6 Million - $89.2 Million
-498,866 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$127.12 - $172.34 $63.4 Million - $86 Million
498,866 New
498,866 $70.1 Million
Q3 2020

Nov 10, 2020
SELL
$127.12 - $172.34 $71.4 Million - $96.8 Million
-561,630 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$93.0 - $171.7 $52.2 Million - $96.4 Million
561,630 New
561,630 $90.1 Million
Q2 2020

Aug 07, 2020
SELL
$93.0 - $171.7 $53.6 Million - $98.9 Million
-576,123 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$82.38 - $131.64 $47.5 Million - $75.8 Million
576,123 New
576,123 $56.4 Million
Q1 2020

May 08, 2020
SELL
$82.38 - $131.64 $47.5 Million - $75.8 Million
-576,123 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$76.53 - $135.58 $44.1 Million - $78.1 Million
576,123 New
576,123 $74.3 Million
Q4 2019

Feb 12, 2020
SELL
$76.53 - $135.58 $38.4 Million - $67.9 Million
-501,123 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$72.81 - $156.91 $36.5 Million - $78.6 Million
501,123 New
501,123 $37.7 Million
Q3 2019

Nov 08, 2019
SELL
$72.81 - $156.91 $35.4 Million - $76.4 Million
-486,601 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$112.21 - $151.95 $54.6 Million - $73.9 Million
486,601 New
486,601 $73.9 Million
Q2 2019

Aug 09, 2019
SELL
$112.21 - $151.95 $62.3 Million - $84.4 Million
-555,196 Closed
0 $0
Q1 2019

May 11, 2020
BUY
$106.67 - $151.68 $2.64 Million - $3.75 Million
24,716 Added 4.66%
555,196 $66.2 Million
Q4 2018

Mar 04, 2019
BUY
$97.32 - $148.76 $51.6 Million - $78.9 Million
530,480 New
530,480 $57.9 Million
Q4 2018

Feb 08, 2019
SELL
$97.32 - $148.76 $44.2 Million - $67.5 Million
-453,871 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$115.31 - $161.51 $52.3 Million - $73.3 Million
453,871 New
453,871 $73.3 Million
Q3 2018

Nov 09, 2018
SELL
$115.31 - $161.51 $47 Million - $65.8 Million
-407,514 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$71.74 - $153.69 $29.2 Million - $62.6 Million
407,514 New
407,514 $53.9 Million
Q2 2018

Jul 23, 2018
SELL
$71.74 - $153.69 $33.5 Million - $71.8 Million
-467,133 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$54.02 - $82.27 $25.2 Million - $38.4 Million
467,133 New
467,133 $34.6 Million
Q1 2018

May 09, 2018
SELL
$54.02 - $82.27 $26.4 Million - $40.2 Million
-488,034 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$47.64 - $56.75 $23.2 Million - $27.7 Million
488,034 New
488,034 $27.2 Million
Q4 2017

Feb 09, 2018
SELL
$47.64 - $56.75 $28.2 Million - $33.6 Million
-592,028 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$35.73 - $47.15 $21.2 Million - $27.9 Million
592,028 New
592,028 $26.9 Million
Q3 2017

Nov 07, 2017
SELL
$35.73 - $47.15 $20.5 Million - $27 Million
-573,205 Closed
0 $0
Q1 2017

May 11, 2018
BUY
N/A
231,952 Added 67.97%
573,205 $17 Million
Q3 2016

Nov 13, 2017
BUY
N/A
341,253
341,253 $0

Others Institutions Holding SRPT

# of Institutions
406
Shares Held
83.7M
Call Options Held
5.27M
Put Options Held
5.94M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $1.65B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email